← Browse by Condition
Medical Condition

cognition

Total Trials
16
Recruiting Now
16
Trial Phases
Phase 2, Phase 3, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for cognition sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cognition Clinical Trials

How many clinical trials are currently recruiting for cognition?
ClinicalMetric currently tracks 16 actively recruiting clinical trials for cognition, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 16. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cognition?
cognition research spans Phase 2 (2 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cognition clinical trial?
Eligibility criteria for cognition trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Phase 3
2
Top Sponsors
Sam Houston State University 1 trial
Fundacion Miguel Servet 1 trial
University Hospital, Bordeaux 1 trial
University of Sao Paulo 1 trial
Distribuidora Biolife SA de CV 1 trial

Recruiting Clinical Trials

NCT07819565
Recruiting
Effects of Pork Protein on Recovery Following Simulated Fireground Activity
Enrollment
20 pts
Location
United States
Sponsor
Sam Houston State University
View Trial →
NCT06677359
Recruiting
Impact of Creatine Monohydrate Micronized Supplementation With or Without Multicomponent Training in Older Adults.
Enrollment
120 pts
Location
Spain
Sponsor
Fundacion Miguel Servet
View Trial →
NCT05322343
Recruiting
Biobank and Brain Health in Bordeaux.
Enrollment
2,050 pts
Location
France
Sponsor
University Hospital, Bordeaux
View Trial →
NCT07792876
Recruiting
Endurance Trial: Ketone and Carbohydrate Supplementation
Enrollment
12 pts
Location
Brazil
Sponsor
University of Sao Paulo
View Trial →
NCT06520878 Phase 2
Recruiting
Impact of NANO-PSO on Cognition in Older Adults with Mild to Moderate Cognitive Impairment
Enrollment
60 pts
Location
Mexico
Sponsor
Distribuidora Biolife SA de CV
View Trial →
NCT07388043
Recruiting
A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Performance at Varying Dosages in Healthy Middle-aged and Older Adults With Self-reported Memory Problems
Enrollment
120 pts
Location
Canada
Sponsor
Rousselot BVBA
View Trial →
NCT06821568
Recruiting
Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
Enrollment
128 pts
Location
United States, Israe...
Sponsor
Hebrew SeniorLife
View Trial →
NCT07263022 Phase 3
Recruiting
Cognitive Strategies in Early Psychosis 2
Enrollment
24 pts
Location
United States
Sponsor
University of Minnesota
View Trial →
NCT06776705
Recruiting
Low-intensity TUS for Sleep Disturbances in Patients With Chronic Tinnitus
Enrollment
14 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
View Trial →
NCT05201534
Recruiting
Interventions in Mathematics and Cognitive Skills
Enrollment
180 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT07293637
Recruiting
Identifying the Neural Correlates of Mental Simulation in Multi-Step Planning
Enrollment
50 pts
Location
United States
Sponsor
New York University
View Trial →
NCT07373444
Recruiting
Westlake Aging Cohort (WeAC)
Enrollment
2,800 pts
Location
China
Sponsor
Westlake University
View Trial →
NCT07675499 Phase 2, Phase 3
Recruiting
Exercise and Intranasal Insulin in Type 2 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Rutgers, The State University ...
View Trial →
NCT07119788
Recruiting
Investigating the Effects of a Haskap Berry Supplement on Cognitive Health
Enrollment
90 pts
Location
United Kingdom
Sponsor
University of Reading
View Trial →
NCT06837246
Recruiting
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
Enrollment
422 pts
Location
United States
Sponsor
Pharmavite LLC
View Trial →
NCT07763392
Recruiting
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan
Enrollment
1,000 pts
Location
United States
Sponsor
The Neurology Center of Southe...
View Trial →

Related Conditions

aging (2) dementia (2) alzheimer disease (2) decision making (2) cognition disorders (2) exercise recovery (1) physical performance parameters (1) muscle damage (1) blood biomarkers (1) stress (1) functionality (1) strength training effects (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology